Market Overview

The Global Rubella Diagnostic Testing Market was valued at USD 1,431.6 million in 2023 and is expected to reach USD 2,264.5 million by 2031 while growing at a CAGR of 5.9% during the forecast period (2024-2031).

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Market Dynamics

This section of the report will analyze various driving and restraining factors that are expected to have a significant impact on the global rubella diagnostic testing market growth. Rubella diagnostic testing identifies the presence of the rubella virus or specific antibodies generated due to rubella infection, a contagious viral illness recognized by rash and fever, also known as German measles. Rubella infection during pregnancy poses significant risks to the fetus, potentially causing congenital rubella syndrome (CRS), resulting in birth defects and developmental disabilities.

High incidence rates in developing countries and increased focus on Congenital Rubella Syndrome (CRS) are driving the rubella diagnostic testing market. However, challenges related to affordability, accessibility, and vaccine-induced immunity may hinder market growth.

Furthermore, the global rubella diagnostic testing industry will be analyzed through various tools including PESTLE analysis, and Porter’s analysis.

Segmentation – By Testing Technique Analysis

The Global Rubella Diagnostic Testing Market is segmented among Latex Agglutination, Enzyme Immunoassay, Radioimmunoassay, Fluorescent Immunoassay, and Other Testing Techniques, based on Testing Technique. In 2023, Enzyme Immunoassay (EIA) accounted for the majority of the market share*.

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Segmentation – By Application Analysis

The Global Rubella Diagnostic Testing Market is segmented among Hospitals, Laboratories, and Other Applications, based on Application. In 2023, Hospitals accounted for the majority of the market share*.

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Global Rubella Diagnostic Testing Market: Regional Analysis

Based on region, the market is divided into six regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. In 2023, North America dominated the market with the highest market share, while Asia Pacific is expected to grow with the highest CAGR during the forecast period (2024 – 2031).

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Competitive Landscape

Some of the key players operating in the market are Abbott Laboratories Inc., Beckman Coulter Inc., Bio Rad Laboratories Inc., Biokit SA, BioMérieux SA, F. Hoffmann-La Roche Ltd, Ortho Clinical Diagnostics, Siemens Healthcare GmbH, Thermo Fisher Scientific Inc., and ZEUS Scientific Inc.

Table of Contents:

1. Research Methodology and Market Scope

• Research Methodology

• Market Scope

2. Executive Summary

3. Global Rubella Diagnostic Testing Market Dynamics

• Drivers

• Restraints

• Opportunity

4. Global Rubella Diagnostic Testing Industry Analysis

• PEST Analysis

• Porter's Five Force Analysis

• Recent Deals Analysis

5. Global Rubella Diagnostic Testing Market Segmentation, By Testing Technique

• Global Rubella Diagnostic Testing Market Share Analysis, By Testing Technique

• Global Rubella Diagnostic Testing Market Growth Analysis, By Testing Technique

• Global Rubella Diagnostic Testing Market Trends, By Testing Technique

o Latex Agglutination

o Enzyme Immunoassay

o Radioimmunoassay

o Fluorescent Immunoassay

o Other Testing Techniques

6. Global Rubella Diagnostic Testing Market Segmentation, By Application

• Global Rubella Diagnostic Testing Market Share Analysis, By Application

• Global Rubella Diagnostic Testing Market Growth Analysis, By Application

• Global Rubella Diagnostic Testing Market Trends, By Application

o Hospitals

o Laboratories

o Other Applications

7. Global Rubella Diagnostic Testing Market Segmentation, By Region

• Global Rubella Diagnostic Testing Market Share Analysis, By Region

• Global Rubella Diagnostic Testing Market Growth Analysis, By Region

• Global Rubella Diagnostic Testing Market Trends, By Region

o North America

o Europe

o Asia Pacific

o Latin America

o Middle East

o Africa

8. Competitive Landscape

• Abbott Laboratories Inc.*

o Company Overview

o Financial Performance

o Key Development/Strategies

o SWOT Analysis

• Beckman Coulter Inc.

• Bio Rad Laboratories Inc.

• Biokit SA

• BioMérieux SA

• F. Hoffmann-La Roche Ltd

• Ortho Clinical Diagnostics

• Siemens Healthcare GmbH

• Thermo Fisher Scientific Inc.

• ZEUS Scientific Inc.

*Similar analysis will be provided for each company listed above.